LUPUS ERYTHEMATOSUS, CUTANEOUS

Clinical trials for LUPUS ERYTHEMATOSUS, CUTANEOUS explained in plain language.

Never miss a new study

Get alerted when new LUPUS ERYTHEMATOSUS, CUTANEOUS trials appear

Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, CUTANEOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Lupus skin treatment trial halted after low enrollment

Disease control Terminated

This study tested an experimental drug called PF-06823859 for adults with lupus who have active skin symptoms. The goal was to see if the drug could reduce skin inflammation and improve symptoms compared to a placebo. The trial was terminated early after enrolling only 8 particip…

Matched conditions: LUPUS ERYTHEMATOSUS, CUTANEOUS

Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

LUPUS ERYTHEMATOSUS, CUTANEOUS

Get alerted when new LUPUS ERYTHEMATOSUS, CUTANEOUS trials appear

Lupus skin treatment trial halted after low enrollment